歐洲醫藥溶劑市場規模、份額及趨勢分析報告－產業概況及2032年預測

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Healthcare Europe Pharmaceutical Solvent Market
请求目录 请求目录 与分析师交谈 与分析师交谈 免费样本报告 免费样本报告 购买前请咨询 提前咨询 立即购买 立即购买

歐洲醫藥溶劑市場規模、份額及趨勢分析報告－產業概況及2032年預測

  • Healthcare
  • Published Report
  • May 2025
  • Europe
  • 350 页面
  • 桌子數： 136
  • 图号： 25
  • Author : Sachin Pawar
立即购买 立即购买 索取樣品 索取樣品
Nucleus Nucleus

通过敏捷供应链咨询解决关税挑战

供应链生态系统分析现已成为 DBMR 报告的一部分

Europe Pharmaceutical Solvent Market

市场规模（十亿美元）

CAGR :  % Diagram

Chart Image USD 1.38 Billion USD 2.08 Billion 2024 2032
Diagram Forecast Period
 2025 –2032
Diagram Market Size (Base Year)
 USD 1.38 Billion
Diagram Market Size (Forecast Year)
 USD 2.08 Billion
Diagram CAGR
 %
Diagram Major Markets Players
  • BASF Corporation
  • Shell PLC
  • Bayer AG
  • Merck KGaA
  • CLARIANT

歐洲製藥溶劑市場細分，按產品（醇、芳香烴、酮、醚、胺、酯、氯化溶劑等）、應用（製藥、研究實驗室、化學等）、國家（德國、英國法國、義大利西班牙、俄羅斯荷蘭瑞士比利時土耳其丹麥瑞典挪威波蘭芬蘭和歐洲其他地區

醫藥溶劑市場

 醫藥溶劑市場規模

  • 2024 年歐洲醫藥溶劑市場規模為13.8 億美元，預計到 2032 年將達到 20.8 億美元，預測期內 複合年增長率為 5.3%。
  • 這一增長受到人口老化、眼部疾病盛行率上升以及眼科技術進步等因素的推動

醫藥溶劑市場醫藥溶劑市場

醫藥溶劑市場分析

  • 醫藥溶劑是藥物配方和製造過程中使用的關鍵成分，在溶解活性成分和促進各種藥物生產過程中的化學反應方面發揮著至關重要的作用。
  • 慢性病發病率的上升、藥品產量的增加以及藥物開發技術的進步極大地推動了對醫藥溶劑的需求。
  • 瑞士憑藉其先進的醫療保健基礎設施、強大的製藥製造基礎以及對高品質藥物製劑日益增長的需求，預計將在製藥溶劑市場佔據主導地位。
  • 預計在預測期內，瑞士將成為醫藥溶劑市場成長最快的地區，這得益於人們對醫療保健品質的認識不斷提高以及對研發的持續投資。
  • 由於酒精在藥物合成、萃取和淨化過程中的廣泛應用，預計將佔據市場主導地位，佔有 29.59% 的份額。其高溶解能力、與各種活性藥物成分 (API) 的兼容性以及法規認可度使其成為整個製藥行業的首選。

報告範圍和醫藥溶劑市場細分     

屬性

醫藥溶劑關鍵市場洞察

涵蓋的領域
  • 副產物：醇、芳香烴、酮、醚、胺、酯、氯化溶劑等
  • 按應用：製藥、研究實驗室、化學及其他

覆蓋國家

歐洲

  • 德國
  • 英國
  • 法國
  •  義大利
  •  西班牙
  •  俄羅斯
  •  荷蘭
  •  瑞士
  •  比利時
  •  火雞
  •  丹麥
  •  瑞典
  •  挪威
  •  波蘭
  •  芬蘭
  •  歐洲其他地區

主要市場參與者
  • 巴斯夫公司（德國）
  • 殼牌公司（英國）
  • 拜耳公司（德國）
  • 默克集團（德國）
  • 科萊恩（瑞士）
  • 三井化學株式會社（日本）
  • 埃克森美孚公司（美國）
  • 陶氏（美國）
  • 諾力昂（荷蘭）
  • 巴西國家石油公司（Braskem）
  • 杜邦（美國）
  • 伊士曼化學公司（美國）
  • 利安德巴塞爾工業控股有限公司（荷蘭）
  • ACTYLIS（美國）
  • SK化學（韓國）
  • Carl Roth GmbH + Co. KG（德國）
  • Chemco UK（英國）
  • PCC集團（德國）
  • Advion Interchim Scientific（美國）

市場機會
  • 生物相似藥和高效能藥物的擴張
  • 臨床試驗和研發投資增加
  • 更重視個人化醫療和孤兒藥

加值資料資訊集

除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察之外，Data Bridge Market Research 策劃的市場報告還包括進出口分析、生產能力概覽、生產消費分析、價格趨勢分析、氣候變遷情景、供應鏈分析、價值鏈分析、原材料/消耗品概覽、供應商選擇標準、PESTLE 分析、波特分析和監管框架。

醫藥溶劑市場趨勢

“歐洲製藥業越來越重視綠色和永續溶劑”

  • 影響歐洲醫藥溶劑市場的一個關鍵趨勢是，受更嚴格的環境法規和企業永續發展目標的推動，對環保和永續溶劑的需求不斷增長。
  • 這種轉變鼓勵使用生物基和低毒溶劑，以減少危險廢物並提高藥物配製和製造過程中工人的安全性
  • 例如，乳酸乙酯和超臨界二氧化碳等綠色溶劑越來越多地被用作藥物合成和萃取過程中傳統石化溶劑的更安全替代品。
  • 這一趨勢正在改變溶劑選擇策略，促進更清潔的生產實踐，並推動整個歐洲製藥產業對永續溶劑技術的需求

醫藥溶劑市場動態

司機

“用於製造各種藥物的酒精溶劑需求增加”

  • 歐洲醫藥溶劑市場正在經歷顯著成長，這得益於對乙醇和異丙醇等醇基溶劑的需求不斷增長。
  • 這些溶劑是藥物配方、合成和淨化過程中不可或缺的一部分。導致這種激增的因素包括慢性病的增加、人口老化以及藥物研發的進步。
  • 此外，產業向綠色化學和永續實踐的轉變正在影響溶劑的選擇，人們越來越傾向於生物基醇溶劑。這一趨勢強調了酒精溶劑在確保藥品功效和安全性方面的關鍵作用。

例如，

  • 2025 年 2 月 Drugs.com 的調查結果顯示，酒精被廣泛用於藥物製劑中，作為溶劑、防腐劑和消毒劑。它的多功能性使其能夠溶解多種活性成分，有助於藥物配製。由於其抗菌特性和對藥物穩定性的有效性，酒精在製造各種口服和外用藥物中起著至關重要的作用
  • 2024 年 8 月，根據 Springer Nature 發表的文章，醇溶劑（特別是甲醇和乙醇）在有效去除藥物製劑（例如 PLGA 微粒）中的殘留溶劑（如二氯甲烷）方面的作用。這反映了藥品製造中對醇基溶劑的需求不斷增長，這是由監管要求和安全有效的藥物輸送系統的需求所推動的
  • 歐洲製藥業對酒精溶劑的依賴日益增加，凸顯了其在藥物開發和製造中的重要角色。隨著產業向永續實踐邁進，對高品質生物基酒精溶劑的需求預計將上升，以確保遵守環境法規並提高產品安全性

醫藥溶劑市場

機會

“生物相似藥和高效藥物的擴張”

  • 歐洲各地生物相似藥和高效活性藥物成分 (HPAPI) 的開發和生產日益增多，大大提升了對高純度、精密級溶劑的需求。
  • 這些溶劑對於確保產品安全、維持化學穩定性以及滿足與處理敏感藥物物質相關的嚴格的控制和監管要求至關重要。
  • 歐洲在生物相似藥審批方面處於領先地位，並擁有強大的監管框架和先進的生物製造基礎設施，推動了該領域的大幅成長。隨著製藥公司擴大複雜生物製劑和強效化合物的生產，對專用溶劑的需求也日益增加。這一趨勢為歐洲醫藥溶劑市場帶來了豐厚且可持續的機遇，尤其是在溶劑創新和客製化等高價值領域。

例如，

  • 2025年2月，根據Dolphin Pharmaceuticals發表的文章，對標靶癌症治療和先進生物製劑的需求不斷增長，正在加速高效活性藥物成分（HPAPI）的生產，而這需要嚴格的製造條件。溶劑和催化劑在實現這些複雜藥物所必需的精確化學反應和淨化方面發揮關鍵作用。這推動了對高品質溶劑的需求，為歐洲醫藥溶劑市場創造了巨大的成長機會
  • 2022 年 8 月，根據 GaBi 發表的文章，歐洲仍處於生物相似藥開發的前沿，歐洲藥品管理局 (EMA) 迄今已在集中監管框架下批准了 88 種生物相似藥。這種領導力促進了生物相似藥製造業的蓬勃發展，需要高純度溶劑進行合成和純化。該地區在生物相似藥領域的主導地位推動了溶劑需求，為市場提供了巨大的機會
  • 2022年7月，根據Rapid Life Sciences Ltd發表的文章，對高效活性藥物成分（HPAPI）藥品的需求不斷增長，正在推動提供端到端解決方案的合約開發和製造組織（CDMO）的作用。這些過程需要精密級溶劑進行合成和配製。隨著 CDMO 活動在歐洲的擴展，對高品質溶劑的需求顯著增加，這為製藥溶劑市場帶來了巨大的機會
  • 歐洲生物相似藥和高效藥物開發的不斷擴大推動了對高純度專用溶劑的持續需求。憑藉強大的監管支援、先進的製造基礎設施以及日益增長的 CDMO 參與度，歐洲完全有能力引領這一領域。這些因素共同為歐洲醫藥溶劑市場帶來了強勁且長期的成長機會

克制/挑戰

“關於製藥溶劑的健康與安全問題”

  • 製藥溶劑，尤其是苯、甲苯、二氯甲烷和丙酮等石化基溶劑，對工人和環境構成重大的健康和安全風險。
  • 長期接觸這些溶劑會導致嚴重的健康問題，包括神經毒性、呼吸系統併發症、皮膚病和器官損傷，尤其是影響肝臟和腎臟。在製造過程中吸入蒸汽，再加上這些化學物質的易燃和揮發性，增加了工作場所事故和環境污染的風險。
  • 這對歐洲醫藥溶劑市場來說是一個巨大的挑戰，因為它限制了配方的靈活性，並增加了製造商的財務和程序負擔。

例如，

  • 2024年10月，根據SCAT歐洲發布的消息，溶劑蒸氣會帶來嚴重危害，包括呼吸系統疾病、皮膚和眼睛刺激、器官損傷、火災或爆炸風險以及環境污染。工作場所中溶劑使用的管理不善可能導致職業事故和違反法規的行為。這些風險需要嚴格的安全協議並增加營運成本，使健康和安全問題成為市場面臨的重大挑戰
  • 2020 年 8 月，根據 Veeprho Pharmaceuticals sro 發布的數據，殘留溶劑是指生產後殘留在藥物物質中的有毒揮發性化合物。即使是微量，它們也會損害藥物的安全性、功效和穩定性，並帶來器官毒性和致癌性等風險。 ICH Q3C (R8) 等嚴格法規要求進行嚴格的測試和移除，這增加了合規成本和複雜性，對市場構成了重大挑戰
  • 2022年，根據ScienceDirect發表的文章，長期職業性接觸有機溶劑會導致認知能力下降、情緒障礙、記憶力喪失、視力和聽力障礙以及週邊神經病變。由於噪音共同暴露而導致的發育神經毒性和聽力惡化進一步增加了風險。這些嚴重的健康影響需要加強安全協議和法規遵循，從而增加成本並對市場構成重大挑戰
  • 與醫藥溶劑（尤其是石化溶劑）相關的健康和安全問題對歐洲醫藥溶劑市場提出了重大挑戰。職業暴露、殘留溶劑毒性和長期健康影響的風險需要嚴格的安全措施、法規遵循和持續監測。這些因素不僅增加了營運成本，也限制了配方靈活性，最終影響了市場的整體效率和競爭力。

醫藥溶劑市場範圍

市場根據產品和應用進行細分。

分割

細分

按產品
  • 酒精
    • 甲醇
    • 乙醇
    • 1-丁醇
    • 2-丁醇
    • 2-甲氧基乙醇
    • 3-甲基-1-丙醇
    • 2-甲基-1-丙醇
    • 1-戊醇
    • 1-丙醇
    • 2-丙醇（異丙醇）
    • 異丙醇
    • 丙二醇
    • 其他的
  • 芳香烴
    • 甲苯
    • 二甲苯
    • 乙苯
    • 其他的
  • 酮類
    • 丙酮
    • 環己酮
    • 甲醚酮
    • 甲乙酮
    • 甲基異丁基酮
    • 其他的
  • 醚
    • 乙醚
    • 四氫呋喃
    • 甲氧基乙烷
    • 甲基叔丁基醚
    • 聚乙二醇
    • 苯甲醚
    • 二正丙醚
    • 其他的
  • 胺
    • 單乙醇胺（MEA）
    • 苯胺
    • 二乙醇胺（DEA）
    • 甲基二乙醇胺（MDEA）
    • 三甲胺
    • 其他的
  • 酯類
    • 乙醯乙酸酯
    • 乙酸乙酯
    • 乙酸丁酯
    • 其他的
  • 氯化溶劑
    • 三氯乙烯（TCE）
    • 二氯甲烷
    • 四氯乙烯（PCE）
    • 1,1,1-三氯乙烷（TCA）
    • 四氯化碳
    • 其他的
  • 其他的

按應用
  • 製藥
  • 研究實驗室
  • 化學
  • 其他的

醫藥溶劑市場

預計到 2025 年，酒精產品將佔據市場主導地位，佔據產品類別中的最大份額

由於醇類在藥物配方、萃取和淨化過程中具有廣泛的適用性，預計到 2025 年它將佔據製藥溶劑市場的主導地位，佔據 29.59% 的最大份額。其良好的溶劑特性、成本效益和監管接受度進一步推動了需求。此外，乙醇和異丙醇等醇類廣泛用於 API 和賦形劑。

預計在預測期內，製藥業在應用領域將佔據最大份額

到 2025 年，由於藥物配方和生產對高純度溶劑的需求不斷增長，預計製藥業將佔據市場主導地位，佔有 54.60% 的最大份額。研發活動的增加、藥品生產的擴大以及嚴格的品質標準進一步推動了該領域的成長。這些溶劑對於確保產品的功效和安全性至關重要。

醫藥溶劑市場區域分析

“瑞士在醫藥溶劑市場佔有最大份額並擁有最高複合年增長率”

  • 歐洲的製藥溶劑市場正在穩步增長，瑞士憑藉其強大的製藥製造基礎、高品質標準和支持性監管環境成為主導國家。
  • 瑞士憑藉其領先的製藥公司、熟練的勞動力以及對藥物開發和生產創新的高度重視，佔據了相當大的份額。
  • 該國重視遵守國際品質規範，並擁有完善的研究和製造基礎設施，這些都增強了市場實力。
  • 此外，先進藥物製劑中高純度溶劑的日益普及以及可持續和綠色化學實踐的日益增長趨勢正在推動整個地區的市場成長

醫藥溶劑市場份額

市場競爭格局提供了競爭對手的詳細資訊。詳細資訊包括公司概況、公司財務狀況、收入、市場潛力、研發投資、新市場計劃、全球影響力、生產基地和設施、生產能力、公司優勢和劣勢、產品發布、產品寬度和廣度、應用優勢。以上提供的數據點僅與公司對市場的關注有關。

市場中主要的市場領導者有：

  • 巴斯夫公司（德國）
  • 殼牌公司（英國）
  • 拜耳公司（德國）
  • 默克集團（德國）
  • 科萊恩（瑞士）
  • 三井化學株式會社（日本）
  • 埃克森美孚公司（美國）
  • 陶氏（美國）
  • 諾力昂（荷蘭）
  • 巴西國家石油公司（Braskem）
  • 杜邦（美國）
  • 伊士曼化學公司（美國）
  • 利安德巴塞爾工業控股有限公司（荷蘭）
  • ACTYLIS（美國）
  • SK化學（韓國）
  • Carl Roth GmbH + Co. KG（德國）
  • Chemco UK（英國）
  • PCC集團（德國）
  • Advion Interchim Scientific（美國）

歐洲醫藥溶劑市場最新動態

  • 5月，拜耳公司宣佈在德國勒沃庫森啟動其新的Solida-1製藥生產設施。該單層工廠預計於 2024 年投入運營，投資額為 3.1169 億美元，將成為世界上最先進的製藥生產工廠之一。 Solida-1 是拜耳 11.3 億美元投資計畫的一部分，旨在加強其全球製藥製造網絡。
  • 7 月，默克完成了對 EyeBio 的收購，透過 Restoret 加強了其眼科產品線，Restoret 是一種用於治療糖尿病性黃斑水腫和新生血管性老年黃斑部病變的新型 Wnt 通路激動劑。該交易包括針對視網膜疾病的額外臨床前資產。此次策略性收購使默克公司的後期產品組合更加多樣化，並支持其推進視力相關疾病創新治療的願景。
  • 11 月，科萊恩在即將於 2024 年 11 月 26 日至 28 日在德里國家首都轄區舉行的 CPHI 印度展會上展示了最新的醫療保健解決方案組合。今年的展會將重點展示科萊恩醫療保健的「印度製造」產品系列、其 Bonthapally 工廠的生產能力，以及其在生物製劑、仿製藥和輔料生產方面的深厚專業知識。
  • 2024 年 6 月，Carl Roth GmbH & Co. KG 位於德國卡爾斯魯厄的工廠因其作為藥用輔料供應商的角色而獲得了 EXCiPACT GMP 認證。
  • 12 月，陶氏與麥格理資產管理公司合作成立了 Diamond Infrastructure Solutions，這是一家專注於營運效率和客戶獲取的新基礎設施提供者。麥格理將收購美國墨西哥灣沿岸部分資產 40% 的股份，並可選擇增至 49%。該交易預計將為陶氏帶來高達 30 億美元的收益 

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE PHARMACEUTICAL SOLVENT MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MARKET APPLICATION COVERAGE GRID

2.7 MULTIVARIATE MODELLING

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PORTER’S FIVE FORCES

4.2 PESTLE ANALYSIS

4.3 CLIMATE CHANGE SCENARIO – EUROPE PHARMACEUTICAL SOLVENT MARKET

4.3.1 ENVIRONMENTAL CONCERNS

4.3.2 INDUSTRY RESPONSE

4.3.3 GOVERNMENT’S ROLE

4.4 PRICING ANALYSIS – EUROPE PHARMACEUTICAL SOLVENT MARKET

4.4.1 RAW MATERIAL COSTS

4.4.2 PURITY AND GRADE

4.4.3 REGULATORY COMPLIANCE COSTS

4.4.4 REGIONAL PRICING VARIABILITY

4.4.5 SUPPLY CHAIN & LOGISTICS

4.4.6 COMPETITIVE LANDSCAPE

4.4.7 FORECASTED PRICING TRENDS (2025–2032)

4.5 PRODUCTION CAPACITY OVERVIEW – EUROPE PHARMACEUTICAL SOLVENT MARKET

4.5.1 KEY PRODUCTION HUBS

4.5.2 CAPACITY UTILIZATION TRENDS

4.5.3 IMPACT OF GREEN CHEMISTRY INITIATIVES

4.5.4 CAPACITY CONSTRAINTS & CHALLENGES

4.6 RAW MATERIAL COVERAGE

4.6.1 IMPORT-EXPORT ANALYSIS

4.6.2 PRODUCTION–CONSUMPTION ANALYSIS

4.7 SUPPLY CHAIN ANALYSIS – EUROPE PHARMACEUTICAL SOLVENT MARKET

4.7.1 OVERVIEW

4.7.2 LOGISTIC COST SCENARIO

4.7.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS

4.8 TARIFFS AND ITS IMPACT ON THE MARKET – EUROPE PHARMACEUTICAL SOLVENT MARKET

4.8.1 DEFINITION AND IMPORTANCE OF TARIFFS IN THE HEALTHCARE SECTOR

4.8.2 GLOBAL VS. REGIONAL TARIFF STRUCTURES

4.8.3 IMPACT OF TARIFFS ON HEALTHCARE COSTS AND ACCESSIBILITY

4.8.4 TARIFF REGULATIONS IN KEY MARKETS

4.8.4.1 MEDICARE/MEDICAID TARIFF POLICIES

4.8.4.2 CMS PRICING MODELS

4.8.4.3 OTHER COUNTRY-SPECIFIC SYSTEMS

4.8.4.4 TARIFFS ON MEDICAL DEVICES & EQUIPMENT

4.8.4.5 IMPORT/EXPORT DUTIES ON MEDICAL EQUIPMENT

4.8.4.6 IMPACT ON PRICING AND AVAILABILITY OF HIGH-END MEDICAL TECHNOLOGY

4.8.5 COST BURDEN ON HOSPITALS AND HEALTHCARE FACILITIES

4.8.6 TARIFF EXEMPTIONS AND INCENTIVES

4.8.7 DUTY-FREE IMPORTS FOR ESSENTIAL MEDICINES AND VACCINES

4.8.8 IMPACT OF TRADE WARS ON THE HEALTHCARE SUPPLY CHAIN

4.8.9 ROLE OF FREE TRADE AGREEMENTS (FTAS) IN REDUCING TARIFFS

4.9 VENDOR SELECTION CRITERIA:

5 REGULATION COVERAGE – EUROPE PHARMACEUTICAL SOLVENT MARKET

5.1 PRODUCT CODES

5.2 CERTIFIED STANDARDS

5.3 SAFETY STANDARDS

5.3.1 MATERIAL HANDLING & STORAGE

5.3.2 TRANSPORT & PRECAUTIONS

5.3.3 HAZARD IDENTIFICATION

 

6 MARKET OVERVIEW

6.1 DRIVER

6.1.1 INCREASE IN THE MANUFACTURING OF INNOVATIVE GENERIC MEDICATIONS, ESPECIALLY WITHIN EMERGING ECONOMIES

6.1.2 INCREASE IN DEMAND FOR ALCOHOL SOLVENTS FOR MANUFACTURING OF VARIOUS DRUGS.

6.1.3 GROWTH IN PHARMACEUTICAL, AND HEALTHCARE SECTOR ACROSS THE EUROPE

6.1.4 RISE IN ADOPTION OF GREEN MATERIALS AND CHEMICALS FOR DRUG

6.2 RESTRAINT

6.2.1 ADOPTION OF GREEN SOLVENTS POSES OPERATIONAL AND TECHNICAL CHALLENGES

6.2.2 SHORTAGE OF SPECIALIZED WORKFORCE HINDERING SOLVENT PRODUCTION EFFICIENCY

6.3 OPPORTUNITY

6.3.1 EXPANSION OF BIOSIMILARS AND HIGH-POTENCY DRUGS

6.3.2 RISE IN CLINICAL TRIALS AND R&D INVESTMENTS

6.3.3 INCREASING FOCUS ON PERSONALIZED MEDICINE AND ORPHAN DRUGS.

6.4 CHALLENGES

6.4.1 COMPETITION FROM ALTERNATIVE FORMULATION TECHNOLOGIES

6.4.2 HEALTH AND SAFETY CONCERNS REGARDING PHARMACEUTICAL SOLVENTS

7 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT

7.1 OVERVIEW

7.2 ALCOHOLS

7.2.1 METHANOL

7.2.2 ETHANOL

7.2.3 1-BUTANOL

7.2.4 2-BUTANOL

7.2.5 2-METHOXYETHANOL

7.2.6 3-METHYL-1-PROPANOL

7.2.7 2-METHYL-1-PROPANOL

7.2.8 1-PENTANOL

7.2.9 1-PROPANOL

7.2.10 2-PROPANOL (ISOPROPYL ALCOHOL)

7.2.11 ISOPROPANOL

7.2.12 PROPYLENE GLYCOL

7.2.13 OTHERS

 

7.3 AROMATIC HYDROCARBONS

7.3.1 TOLUENE

7.3.2 XYLENE

7.3.3 ETHYLBENZENE

7.3.4 OTHERS

7.4 KETONES

7.4.1 ACETONE

7.4.2 CYCLOHEXANONE

7.4.3 METHYL ETHER KETONE

7.4.4 METHYL ETHYL KETONE

7.4.5 METHYL ISOBUTYL KETONE

7.4.6 OTHERS

7.5 ETHERS

7.5.1 DIETHYL ETHER

7.5.2 TETRAHYDROFURAN

7.5.3 METHOXYMETHANE

7.5.4 METHYL TERT-BUTYL ETHER

7.5.5 POLYETHYLENE GLYCOL

7.5.6 ANISOLE

7.5.7 DI-N-PROPYL ETHER

7.5.8 OTHERS

7.6 AMINE

7.6.1 MONOETHANOLAMIDE (MEA)

7.6.2 ANILINE

7.6.3 DIETHANOLAMINE (DEA)

7.6.4 METHYL DIETHANOLAMINE (MDEA)

7.6.5 TRIMETHYLAMINE

7.6.6 OTHERS

7.7 ESTERS

7.7.1 ACETYL ACETATE

7.7.2 ETHYL ACETATE

7.7.3 BUTYL ACETATE

7.7.4 OTHERS

7.8 CHLORINATED SOLVENTS

7.8.1 TRICHLOROETHYLENE (TCE)

7.8.2 DICHLOROMETHANE

7.8.3 PERCHLOROETHYLENE (PCE)

7.8.4 TRICHLOROETHANE (TCA)

7.8.5 CARBON TETRACHLORIDE

7.8.6 OTHERS

7.9 OTHERS

8 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 PHARMACEUTICAL

8.3 RESEARCH LABORATORIES

8.4 CHEMICAL

8.5 OTHERS

9 EUROPE PHARMACEUTICAL SOLVENT MARKET BY COUNTRIES

9.1 EUROPE

9.1.1 SWITZERLAND

9.1.2 ITALY

9.1.3 GERMANY

9.1.4 FRANCE

9.1.5 U.K.

9.1.6 SPAIN

9.1.7 BELGIUM

9.1.8 NETHERLANDS

9.1.9 RUSSIA

9.1.10 TURKEY

9.1.11 LUXEMBURG

9.1.12 REST OF EUROPE

10 EUROPE PHARMACEUTICAL SOLVENT MARKET: COMPANY LANDSCAPE

10.1 COMPANY SHARE ANALYSIS: EUROPE

11 SWOT ANALYSIS

12 COMPANY PROFILES

12.1 BASF CORPORATION

12.1.1 COMPANY SNAPSHOT

12.1.2 PRODUCT PORTFOLIO

12.1.3 RECENT UPDATES

12.2 SHELL PLC

12.2.1 COMPANY SNAPSHOT

12.2.2 REVENUE ANALYSIS

12.2.3 PRODUCT PORTFOLIO

12.2.4 RECENT DEVELOPMENT

 

12.3 BAYER AG

12.3.1 COMPANY SNAPSHOT

12.3.2 REVENUE ANALYSIS

12.3.3 PRODUCT PORTFOLIO

12.3.4 RECENT DEVELOPMENT

12.4 MERCK KGAA

12.4.1 COMPANY SNAPSHOT

12.4.2 REVENUE ANALYSIS

12.4.3 PRODUCT PORTFOLIO

12.4.4 RECENT UPDATES

12.5 CLARIANT

12.5.1 COMPANY SNAPSHOT

12.5.2 REVENUE ANALYSIS

12.5.3 PRODUCT PORTFOLIO

12.5.4 RECENT DEVELOPMENT

12.6 ACTYLIS

12.6.1 COMPANY SNAPSHOT

12.6.2 PRODUCT PORTFOLIO

12.6.3 RECENT UPDATES

12.7 ADVION INTERCHIM SCIENTIFIC

12.7.1 COMPANY SNAPSHOT

12.7.2 PRODUCT PORTFOLIO

12.7.3 RECENT DEVELOPMENT

12.8 BRASKEM

12.8.1 COMPANY SNAPSHOT

12.8.2 PRODUCT PORTFOLIO

12.8.3 RECENT DEVELOPMENT

12.9 CARL ROTH GMBH + CO. KG

12.9.1 COMPANY SNAPSHOT

12.9.2 PRODUCT PORTFOLIO

12.9.3 RECENT DEVELOPMENT/NEWS

12.1 CHEMCO UK

12.10.1 COMPANY SNAPSHOT

12.10.2 PRODUCT PORTFOLIO

12.10.3 RECENT DEVELOPMENT

12.11 DOW

12.11.1 COMPANY SNAPSHOT

12.11.2 REVENUE ANALYSIS

12.11.3 PRODUCT PORTFOLIO

12.11.4 RECENT DEVELOPMENT

12.12 DUPONT

12.12.1 COMPANY SNAPSHOT

12.12.2 REVENUE ANALYSIS

12.12.3 PRODUCT PORTFOLIO

12.12.4 RECENT DEVELOPMENT

12.13 EASTMAN CHEMICAL COMPANY

12.13.1 COMPANY SNAPSHOT

12.13.2 REVENUE ANALYSIS

12.13.3 PRODUCT PORTFOLIO

12.13.4 RECENT DEVELOPMENT

12.14 EXXON MOBIL CORPORATION

12.14.1 COMPANY SNAPSHOT

12.14.2 REVENUE ANALYSIS

12.14.3 PRODUCT PORTFOLIO

12.14.4 RECENT DEVELOPMENT

12.15 LYONDELLBASELL INDUSTRIES HOLDINGS B.V.

12.15.1 COMPANY SNAPSHOT

12.15.2 REVENUE ANALYSIS

12.15.3 PRODUCT PORTFOLIO

12.15.4 RECENT DEVELOPMENT

12.16 MITSUI CHEMICALS, INC.

12.16.1 COMPANY SNAPSHOT

12.16.2 REVENUE ANALYSIS

12.16.3 PRODUCT PORTFOLIO

12.16.4 RECENT DEVELOPMENT

12.17 NOURYON

12.17.1 COMPANY SNAPSHOT

12.17.2 PRODUCT PORTFOLIO

12.17.3 RECENT UPDATES

12.18 PCC GROUP

12.18.1 COMPANY SNAPSHOT

12.18.2 PRODUCT PORTFOLIO

12.18.3 RECENT UPDATES

12.19 SEQENS

12.19.1 COMPANY SNAPSHOT

12.19.2 PRODUCT PORTFOLIO

12.19.3 RECENT DEVELOPMENT

 

12.2 SK CHEMICALS

12.20.1 COMPANY SNAPSHOT

12.20.2 PRODUCT PORTFOLIO

12.20.3 RECENT DEVELOPMENT

13 QUESTIONNAIRE

14 RELATED REPORTS

表格列表

TABLE 1 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 2 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)

TABLE 3 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)

TABLE 4 EUROPE ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 5 EUROPE AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 6 EUROPE KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 7 EUROPE ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 8 EUROPE AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 9 EUROPE ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 10 EUROPE CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 11 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 12 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 13 SWITZERLAND PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 14 SWITZERLAND PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)

TABLE 15 SWITZERLAND PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)

TABLE 16 SWITZERLAND ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 17 SWITZERLAND AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 18 SWITZERLAND KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 19 SWITZERLAND ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 20 SWITZERLAND AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 21 SWITZERLAND ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 22 SWITZERLAND CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 23 SWITZERLAND PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 24 ITALY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 25 ITALY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)

TABLE 26 ITALY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)

TABLE 27 ITALY ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 28 ITALY AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 29 ITALY KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 30 ITALY ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 31 ITALY AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 32 ITALY ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 33 ITALY CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 34 ITALY PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 35 GERMANY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 36 GERMANY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)

TABLE 37 GERMANY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)

TABLE 38 GERMANY ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 39 GERMANY AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 40 GERMANY KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 41 GERMANY ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 42 GERMANY AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 43 GERMANY ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 44 GERMANY CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 45 GERMANY PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 46 FRANCE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 47 FRANCE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)

TABLE 48 FRANCE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)

TABLE 49 FRANCE ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 50 FRANCE AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 51 FRANCE KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 52 FRANCE ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 53 FRANCE AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 54 FRANCE ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 55 FRANCE CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 56 FRANCE PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 57 U.K. PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 58 U.K. PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)

TABLE 59 U.K. PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)

TABLE 60 U.K. ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 61 U.K. AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 62 U.K. KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 63 U.K. ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 64 U.K. AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 65 U.K. ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 66 U.K. CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 67 U.K. PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 68 SPAIN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 69 SPAIN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)

TABLE 70 SPAIN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)

TABLE 71 SPAIN ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 72 SPAIN AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 73 SPAIN KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 74 SPAIN ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 75 SPAIN AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 76 SPAIN ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 77 SPAIN CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 78 SPAIN PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 79 BELGIUM PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 80 BELGIUM PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)

TABLE 81 BELGIUM PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)

TABLE 82 BELGIUM ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 83 BELGIUM AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 84 BELGIUM KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 85 BELGIUM ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 86 BELGIUM AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 87 BELGIUM ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 88 BELGIUM CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 89 BELGIUM PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 90 NETHERLANDS PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 91 NETHERLANDS PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)

TABLE 92 NETHERLANDS PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)

TABLE 93 NETHERLANDS ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 94 NETHERLANDS AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 95 NETHERLANDS KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 96 NETHERLANDS ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 97 NETHERLANDS AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 98 NETHERLANDS ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 99 NETHERLANDS CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 100 NETHERLANDS PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 101 RUSSIA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 102 RUSSIA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)

TABLE 103 RUSSIA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)

TABLE 104 RUSSIA ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 105 RUSSIA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 106 RUSSIA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 107 RUSSIA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 108 RUSSIA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 109 RUSSIA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 110 RUSSIA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 111 RUSSIA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 112 TURKEY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 113 TURKEY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)

TABLE 114 TURKEY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)

TABLE 115 TURKEY ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 116 TURKEY AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 117 TURKEY KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 118 TURKEY ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 119 TURKEY AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 120 TURKEY ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 121 TURKEY CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 122 TURKEY PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 123 LUXEMBURG PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 124 LUXEMBURG PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)

TABLE 125 LUXEMBURG PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)

TABLE 126 LUXEMBURG ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 127 LUXEMBURG AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 128 LUXEMBURG KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 129 LUXEMBURG ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 130 LUXEMBURG AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 131 LUXEMBURG ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 132 LUXEMBURG CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 133 LUXEMBURG PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)

TABLE 134 REST OF EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)

TABLE 135 REST OF EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)

TABLE 136 REST EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/METRIC TONS)

图片列表

FIGURE 1 EUROPE PHARMACEUTICAL SOLVENT MARKET: SEGMENTATION

FIGURE 2 EUROPE PHARMACEUTICAL SOLVENT MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE PHARMACEUTICAL SOLVENT MARKET: DROC ANALYSIS

FIGURE 4 EUROPE PHARMACEUTICAL SOLVENT MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE PHARMACEUTICAL SOLVENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE PHARMACEUTICAL SOLVENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE PHARMACEUTICAL SOLVENT MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 EUROPE PHARMACEUTICAL SOLVENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE PHARMACEUTICAL SOLVENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE PHARMACEUTICAL SOLVENT MARKET: SEGMENTATION

FIGURE 11 INCREASE IN THE MANUFACTURING OF INNOVATIVE GENERIC MEDICATIONS, ESPECIALLY WITHIN EMERGING ECONOMIES IS DRIVING THE GROWTH OF THE EUROPE PHARMACEUTICAL SOLVENT MARKET FROM 2025 TO 2032

FIGURE 12 THE ALCOHOLS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE PHARMACEUTICAL SOLVENT MARKET IN 2025 AND 2032

FIGURE 13 EUROPE PHARMACEUTICAL SOLVENT MARKET EXECUTIVE SUMMARY

FIGURE 14 STRATEGIC DECISIONS

FIGURE 15 DROC ANALYSIS

FIGURE 16 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY PRODUCT, 2024

FIGURE 17 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY PRODUCT, 2025 TO 2032 (USD THOUSAND)

FIGURE 18 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY PRODUCT, CAGR (2025- 2032)

FIGURE 19 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 20 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY APPLICATION, 2024

FIGURE 21 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY APPLICATION, 2025 TO 2032 (USD THOUSAND)

FIGURE 22 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY APPLICATION, CAGR (2025- 2032)

FIGURE 23 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 24 EUROPE PHARMACEUTICAL SOLVENT MARKET SNAPSHOT

FIGURE 25 EUROPE PHARMACEUTICAL SOLVENT MARKET: COMPANY SHARE 2024 (%)

查看详细信息 Right Arrow

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

Frequently Asked Questions

市场是基于 歐洲製藥溶劑市場細分，按產品（醇、芳香烴、酮、醚、胺、酯、氯化溶劑等）、應用（製藥、研究實驗室、化學等）、國家（德國、英國、法國、義大利、西班牙、俄羅斯、荷蘭、瑞士、比利時、土耳其、丹麥、瑞典、挪威、波蘭、芬蘭和歐洲其他地區） 进行细分的。
在2024年，歐洲醫藥溶劑市場的规模估计为1.38 USD Billion美元。
歐洲醫藥溶劑市場预计将在2025年至2032年的预测期内以CAGR 5.3%的速度增长。
市场上的主要参与者包括BASF Corporation, Shell PLC, Bayer AG, Merck KGaA, CLARIANT。

浏览相关页面

Banner
Testimonial
Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future